Robert Tansley Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 6

  • Med. Deal Size

  • Med. Valuation

Robert Tansley General Information

Biography

Dr. Robert Tansley serves as a Partner at Cambridge Innovation Capital. He serves as Board Member at Sortera Bio. He also serves as a Board Member at T-Therapeutics. He also serves as a Board Member at Pretzel Therapeutics. After seven years working in hospital medicine, Robert worked in development and regulatory roles at Sanofi, the MHRA, and Roche. Robert then spent a decade at early-stage biotech companies including Arakis (sold to Sosei Inc), founder and Chief Executive Officer at Treague, founding Chief Executive Officer of the University of Copenhagen spin-out Avilex Pharma, and part of the founding management team of KalVista (Nasdaq: KALV). Robert qualified in medicine from UCL. He is a member of the Royal College of Obstetricians & Gynaecologists and the Faculty of Pharmaceutical Medicine and has an MBA from London Business School and an M.Phil in Biostatistics from the University of Cambridge. Robert manages CIC's investments in Abcodia, Carrick Therapeutics, CMR Surgical, Gyroscope, and Morphogen -IX. He served as a Board Member at Inivata & Roca Test. He served as a Board Member & Investor Director at PetMedix. He also serves as Chairman at Exvastat. He served as Investment Director at Exvastat.

Contact Information

Primary Position
Education
Cambridge University, M.Phil (Master of Philosophy)
London Business School, MBA (Master of Business Administration)
University College London, Bachelor's
Gender
Male
Email
ro
Phone
+44 01223
Address
  • 22 Station Road
  • Cambridge CB1 2JD
  • England, United Kingdom
+44 01223

Robert Tansley Positions (1)

Firm name Firm type Title Location Industry Since
Cambridge Innovation Capital Investor Partner Cambridge, United Kingdom Venture Capital

Robert Tansley Board Seats (6)

Company Industry Ownership Status Financing Status Location Since
Carrick Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Dublin, Ireland
Exvastat Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Microbiotica Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, United Kingdom
Pretzel Therapeutics Biotechnology Privately Held (backing) Venture Capital-Backed Waltham, MA
Sortera Bio Biotechnology Privately Held (no backing) Corporation United Kingdom

Robert Tansley Lead Partner on Deals (21)

Robert Tansley has been the lead partner on 21 deals. Their latest deal was with T-Therapeutics, a drug discovery company. The deal was made for on 15-Nov-2023.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
T-Therapeutics 15-Nov-2023 Early Stage VC (Series A) Completed Drug Discovery Cambridge, United Kingdom
Pretzel Therapeutics 12-Sep-2022 Completed Biotechnology Waltham, MA
Microbiotica 07-Mar-2022 Completed Drug Discovery Cambridge, United Kingdom
Carrick Therapeutics 03-Mar-2022 Completed Drug Discovery Dublin, Ireland
PetMedix 08-Sep-2021 Completed Drug Discovery Cambridge, United Kingdom
PetMedix 19-May-2020 Completed Drug Discovery Cambridge, United Kingdom
STORM Therapeutics 20-May-2019 Completed Drug Discovery Cambridge, United Kingdom
Congenica 30-Apr-2019 Completed Decision/Risk Analysis Cambridge, United Kingdom
Morphogen-IX 18-Dec-2018 Early Stage VC (Series B) Completed Drug Discovery Cambridge, United Kingdom
Microbiotica 24-Oct-2018 Early Stage VC Completed Drug Discovery Cambridge, United Kingdom

Robert Tansley Network (258)

Board Members (113)

Name Company Representing Location From
Richard Sandberg ROCA Test Self Cambridge, United Kingdom
Thomas Hulme Carrick Therapeutics GV Dublin, Ireland
STORM Therapeutics Cambridge Enterprise Cambridge, United Kingdom
Carrick Therapeutics Cambridge Enterprise Dublin, Ireland
T-Therapeutics F-Prime Capital Cambridge, United Kingdom

Portfolio Executives (137)

Name Company Role Deal date Location
Alison Lloyd T-Therapeutics Head of Finance 15-Nov-2023 Cambridge, United Kingdom
E-Chiang Lee Ph.D T-Therapeutics Executive Vice President, Research 15-Nov-2023 Cambridge, United Kingdom
T-Therapeutics Chairman 15-Nov-2023 Cambridge, United Kingdom
T-Therapeutics Co-Founder, Board Member & Chief Executive Officer 15-Nov-2023 Cambridge, United Kingdom
Pretzel Therapeutics Chief Executive Officer & Chairman 12-Sep-2022 Waltham, MA

Fund Team Members (8)

Name Investor Fund Fund Location
Anne Horgan Ph.D Cambridge Innovation Capital Cambridge Innovation Capital I Cambridge, United Kingdom
Anne Horgan Ph.D Cambridge Innovation Capital Cambridge Innovation Capital II Cambridge, United Kingdom
Cambridge Innovation Capital Cambridge, United Kingdom
Cambridge Innovation Capital Cambridge, United Kingdom
Cambridge Innovation Capital Cambridge, United Kingdom

Robert Tansley Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Cambridge Innovation Capital I Cambridge Innovation Capital Venture Capital - Early Stage Evergreen
Cambridge Innovation Capital II Cambridge Innovation Capital Venture - General Closed 2022

Robert Tansley FAQs

  • Who is Robert Tansley?

    Dr. Robert Tansley serves as a Partner at Cambridge Innovation Capital.

  • How much does Robert Tansley typically invest?

    Robert Tansley's median deal size is .

  • What is Robert Tansley’s main position?

    Robert Tansley’s primary position is Partner.

  • What are the contact details for Robert Tansley?

    Robert Tansley’s email address is ro and his phone number is +44 01223 .

  • How many active board seats does Robert Tansley hold?

    Robert Tansley holds 6 board seats including Carrick Therapeutics, Exvastat, Microbiotica, Pretzel Therapeutics, and Sortera Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »